Flexible Data Schema: A drug safety database should allow for the customisation of data fields and schema to align with the unique requirements of different pharmaceutical companies regulatory bodies.
Configurable Workflows: The database should offer configurable workflows that allow users to define and automate various pharmacovigilance processes.
Scalability: As pharmacovigilance databases accumulate large volumes of safety-related data over time, scalability is essential to support growing data storage and processing requirements.
Integration Capabilities: The database should support seamless integration with external systems and data sources, such as electronic health records (EHRs), clinical trial databases, and spontaneous reporting systems.